ADHD Home > Alternatives to Strattera
In addition to Strattera, there are two other non-stimulant medications approved for treating ADHD -- Intuniv® (guanfacine ER) and Kapvay® (clonidine ER). Intuniv and Kapvay are approved for treating ADHD in individuals 6 though 17 years old; they are not yet approved for use in adults.
Like Strattera, it is not a controlled substance. Intuniv is a long-acting form of guanfacine. The short-acting version of guanfacine (Tenex®) is approved for treating high blood pressure and has been used for quite some time in an "off-label" fashion for treating ADHD. Similarly, Kapvay is a long-acting version of clonidine (Catapres®), an old blood pressure medication.
Sometimes, when approved ADHD medications have not worked for a child (or cannot be taken due to side effects), your child's healthcare provider may suggest a medicine considered "off-label" for the treatment of ADHD. Using a prescription medicine off-label means using it to treat a disease or condition for which the U.S. Food and Drug Administration (FDA) has not approved it.
Although the FDA regulates how a medication can be advertised or promoted by the manufacturer, these regulations do not restrict a healthcare provider's ability to prescribe the medication for different conditions, in different doses, or for different lengths of time. The practice of prescribing medications for periods of time or for conditions not FDA-approved is known as "off-label" use.
The following are medications that have not been approved for the treatment of ADHD but are sometimes used to treat ADHD: